Bain Capital Life Sciences Investors’s X4 Pharmaceuticals XFOR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.07M | Hold |
|
|||||
|
2025
Q1 | $4M | Hold |
|
|||||
|
2024
Q4 | $12.4M | Hold |
|
|||||
|
2024
Q3 | $11.3M | Hold |
|
|||||
|
2024
Q2 | $9.81M | Hold |
|
|||||
|
2024
Q1 | $23.5M | Hold |
|
|||||
|
2023
Q4 | $14.2M | Buy |
|
|||||
|
2023
Q3 | $17.4M | Hold |
|
|||||
|
2023
Q2 | $31M | Buy |
|
|||||
|
2023
Q1 | $10.6M | Hold |
|
|||||
|
2022
Q4 | $12.1M | Buy |
|
|||||
|
2022
Q3 | $10.9M | Buy |
|
|||||
|
2022
Q2 | $2.91M | Hold |
|
|||||
|
2022
Q1 | $5.28M | Buy |
|
|||||
|
2021
Q4 | $6.61M | Buy |
|
|||||
|
2021
Q3 | $11.2M | Hold |
|
|||||
|
2021
Q2 | $13.8M | Hold |
|
|||||
|
2021
Q1 | $18.2M | Buy |
|
|||||
|
2020
Q4 | $10.6M | Hold |
|
|||||
|
2020
Q3 | $11.2M | Hold |
|
|||||
|
2020
Q2 | $15.4M | Hold |
|
|||||
|
2020
Q1 | $16.5M | Hold |
|
|||||
|
2019
Q4 | $17.6M | Buy |
|